This article accompanies the No Infection video "How Antibiotics Changed the World โ And Why We Might Lose Them," published this week. It is written for a general audience โ no prior medical or scientific knowledge required. The article covers the complete arc: discovery, mechanism, impact on human health, the antimicrobial resistance crisis, and the current frontiers of the scientific response. Full bibliography with clickable links at the bottom.
Before 1928, a small cut could kill you. A tooth infection could reach your brain. Having a baby could mean dying from fever a week later. Surgery was so dangerous that many surgeons refused to operate unless the patient was already dying from something else. This is the story of how one contaminated petri dish changed all of that โ and why we may be at risk of losing what it gave us.
The World Before โ Why This Discovery Mattered So Much
It is genuinely difficult, in 2026, to imagine the world that existed before antibiotics. Bacterial infections were everywhere, and they were frequently fatal โ not because medicine was primitive in all respects, but because the specific tool needed to fight bacteria did not exist. Surgeons had developed sterile technique, anesthesia had been established, germ theory was understood. And yet, a patient who developed a post-operative wound infection still had no effective treatment beyond the immune system's own resources and supportive care.
Puerperal fever โ bacterial infection of the uterus following childbirth โ had killed women for centuries. Even after Ignaz Semmelweis demonstrated in the 1840s that handwashing dramatically reduced maternal mortality, and even after the adoption of sterile technique in obstetric practice, infections still occurred and still killed. Pneumonia was described by William Osler as "the captain of the men of death." Bacterial meningitis was nearly universally fatal. Tuberculosis killed an estimated one billion people in the 19th century alone.
A scratch from a rose thorn that became infected could kill a healthy adult through sepsis. A tooth abscess that spread to the jaw could reach the brain. These were not rare events. They were the expected reality of bacterial illness in a world without antibiotics.
The Discovery โ An Accident That Almost Didn't Happen
In September 1928, Alexander Fleming, a bacteriologist at St. Mary's Hospital in London, returned from a holiday to find that one of his petri dishes had been contaminated with a mold โ Penicillium notatum. Most researchers would have discarded it. Fleming noticed something unusual: around the mold, there was a clear halo โ a zone where the bacteria had died. The mold was producing something that killed them.
He called it penicillin. He published his findings in the British Journal of Experimental Pathology in 1929. And then โ almost nothing happened. Fleming could not purify or concentrate the substance in clinically useful quantities. His paper attracted little attention. The discovery sat in the scientific literature for more than a decade.
It took another pair of scientists โ Howard Florey and Ernst Chain at Oxford University โ to return to Fleming's work in 1939 and develop a method to purify penicillin in sufficient quantities for clinical use. In 1941, they treated their first human patient: Albert Alexander, a policeman dying of a bacterial infection from a scratch on his face. The results were dramatic โ he began recovering. The supply of penicillin ran out, and he ultimately died โ but the proof of principle was established.
During the Second World War, with the urgent need for a drug that could prevent soldiers from dying of infected wounds, the US government funded the mass production of penicillin at an extraordinary scale. By June 1944, when Allied forces landed on the beaches of Normandy, soldiers had access to penicillin. Bacterial infection โ which had killed more soldiers than enemy fire in every previous major war in history โ was survivable. In 1945, Fleming, Florey, and Chain shared the Nobel Prize in Physiology or Medicine.
How Antibiotics Work โ In Plain English
An antibiotic is a substance that either kills bacteria directly or stops them from reproducing. Different classes of antibiotics work by targeting different critical structures or processes in bacterial cells. Understanding this โ even at a basic level โ helps explain both why antibiotics are so effective and why resistance develops.
| Antibiotic class | What it targets | Plain English | Examples |
|---|---|---|---|
| Beta-lactams | Bacterial cell wall synthesis | Prevents bacteria from building the wall that holds them together โ they burst | Penicillin, amoxicillin, cephalosporins |
| Macrolides | Protein synthesis (50S ribosome) | Shuts down the machinery bacteria use to make proteins they need to survive | Azithromycin, erythromycin |
| Tetracyclines | Protein synthesis (30S ribosome) | Blocks a different part of the same protein-making machinery | Doxycycline, tetracycline |
| Fluoroquinolones | DNA replication | Prevents bacteria from copying their own DNA โ they cannot multiply | Ciprofloxacin, levofloxacin |
| Aminoglycosides | Protein synthesis (30S ribosome) | Causes bacteria to misread their own genetic code โ producing faulty proteins | Gentamicin, amikacin |
| Glycopeptides | Cell wall synthesis (different mechanism) | Blocks the building blocks of the bacterial cell wall โ used when beta-lactams fail | Vancomycin, teicoplanin |
The crucial point for non-specialists: antibiotics only work on bacteria. They have no effect whatsoever on viruses. A common cold, influenza, COVID-19, and most sore throats are caused by viruses. Taking an antibiotic for a viral infection does not help the patient recover faster, does not reduce the severity of the illness, and does not prevent complications. But it does expose your gut microbiome to disruption, it can cause side effects, and โ most importantly โ it contributes to selection pressure for resistant bacteria. This is why the decision of when not to prescribe an antibiotic is as important as the decision of when to prescribe one.
How Antibiotics Transformed Medicine โ The Full Picture
The impact of antibiotics on human health was not a single event โ it was a cascade of transformations that unfolded over decades and continues to the present. Each one built on the last.
Mortality from infectious disease collapsed. US life expectancy rose from approximately 63 years in 1940 to 70 years by 1970 โ a gain of seven years in three decades, with antibiotics and improved vaccination playing major roles. Infant and child mortality from bacterial causes dropped dramatically. Puerperal fever, which had killed mothers for centuries, became treatable. Bacterial meningitis went from near-universally fatal to survivable.
Surgery was transformed. Before antibiotics, surgical infection โ wound fever โ was a major cause of post-operative death even after the adoption of sterile technique. With prophylactic and therapeutic antibiotics available, surgeons could operate on parts of the body that had previously been too dangerous: the heart, the lungs, joint replacements, transplanted organs. The antibiotic cover that surrounds every elective surgical procedure today is so routine that patients and clinicians alike rarely reflect on its necessity.
Cancer treatment was transformed. Many chemotherapy regimens work by suppressing the immune system as an unavoidable side effect of killing cancer cells. Immunocompromised patients are highly vulnerable to bacterial infections that their immune systems cannot adequately fight. Without antibiotics to manage these infections, modern cancer treatment โ as aggressive and effective as it has become โ would be far less possible. The same is true for the immunosuppression required to prevent transplant rejection.
Premature care was transformed. Neonatal intensive care medicine is only possible because bacterial infections in premature infants, whose immune systems are immature, can be treated. The extraordinary survival rates of premature babies born at 24, 25, 26 weeks of gestation depend fundamentally on the ability to manage the bacterial infections to which those infants are almost inevitably exposed.
The Golden Age โ And Why It Ended
Between 1940 and 1980, scientists discovered more than 20 new classes of antibiotics. Each new class worked through a different mechanism, targeting a different part of bacterial biology, and each was able to treat infections that had developed resistance to earlier drugs. This period โ the golden age of antibiotic discovery โ gave medicine a toolbox of extraordinary breadth.
After 1980, the rate of new antibiotic class discovery dropped dramatically. Since the approval of daptomycin in 2003, there has been very limited addition of genuinely new antibiotic classes to the clinical toolkit. The reasons are both scientific and economic: finding compounds that are genuinely novel, effective, and safe is extremely hard. And antibiotics โ taken for short courses, often curative, with fixed reimbursement โ generate less revenue than drugs for chronic conditions taken daily for years. The business model of pharmaceutical development does not align well with the public health imperative of antibiotic innovation.
Antimicrobial Resistance โ The Present Crisis
Bacteria reproduce with extraordinary speed โ a single organism can produce a billion descendants in 24 hours. In that reproductive torrent, random mutations occur constantly. Most are neutral or harmful to the bacterium. But some, by chance, confer resistance to an antibiotic โ the ability to neutralize the drug, pump it out of the cell, or alter the target it binds to. In the presence of an antibiotic, these resistant organisms have an enormous selective advantage: all their non-resistant competitors die, and they survive and multiply.
Every use of an antibiotic โ necessary or unnecessary โ is a selection event. The more antibiotics are used, the faster resistance develops and spreads. We have accelerated this process in several ways: prescribing antibiotics for viral infections where they are useless, using them as growth promoters in livestock farming on an industrial scale, and making them available over the counter without prescription in many countries.
The 2022 Lancet study โ the most comprehensive global analysis of antimicrobial resistance burden ever conducted โ estimated that resistant infections were directly responsible for approximately 1.27 million deaths in 2019, and associated with 4.95 million deaths where resistance played a contributing role. That is more deaths than HIV/AIDS. More than malaria. And the trajectory without intervention is worse: projections have estimated that, by 2050, antimicrobial resistance could account for 10 million deaths per year and represent one of the leading causes of death globally.
"We were given one of the most powerful tools in the history of medicine. And we began using it carelessly before we had finished celebrating."
No Infection Consulting & Education ยท June 2026What Comes Next โ The Frontiers of the Response
What Every Person Can Do
Fleming's 1945 warning was not addressed to governments or pharmaceutical companies. It was addressed to everyone who would ever take an antibiotic. The choices that determine whether we maintain effective antibiotics are distributed across billions of individual decisions โ by patients, physicians, pharmacists, farmers, and policymakers.
Take antibiotics only when a physician determines they are genuinely needed. Complete the full prescribed course โ stopping early when you feel better does not save the remaining tablets for later; it creates exactly the conditions for selecting resistant bacteria. Never take antibiotics prescribed for someone else. Never share your prescription. And when a physician tells you that your illness is viral and an antibiotic won't help โ trust that advice. It is one of the most important things a clinician can say, and one of the most frequently resisted.
These are not dramatic gestures. They are the ordinary choices that, multiplied across a population, determine whether the antibiotic era continues or begins to end.
doi.org/10.1111/j.1365-2141.1929.tb05244.x
nobelprize.org/prizes/medicine/1945/summary
doi.org/10.11622/smedj.2015105
doi.org/10.1016/S0140-6736(21)02724-0
who.int/publications/i/item/9789241509763
amr-review.org
cdc.gov/antimicrobial-resistance/data-research/threats
doi.org/10.1016/j.cell.2020.01.021
doi.org/10.1038/s41591-019-0437-z
gardp.org
cdc.gov/antibiotic-use/stewardship-report
Stay ahead with physician-led IPC intelligence, outbreak updates, and online certification courses.
View All Courses โ